NAUTILUS INC (NLS)

US63910B1026 - Common Stock

0.8204  +0.08 (+11.2%)

After market: 0.85 +0.03 (+3.61%)

Fundamental Rating

2

Overall NLS gets a fundamental rating of 2 out of 10. We evaluated NLS against 32 industry peers in the Leisure Products industry. The financial health of NLS is average, but there are quite some concerns on its profitability. NLS has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

NLS had negative earnings in the past year.
In the past year NLS had a positive cash flow from operations.
In multiple years NLS reported negative net income over the last 5 years.
In multiple years NLS reported negative operating cash flow during the last 5 years.

1.2 Ratios

NLS has a Return On Assets of -35.77%. This is in the lower half of the industry: NLS underperforms 79.41% of its industry peers.
The Return On Equity of NLS (-84.89%) is worse than 76.47% of its industry peers.
Industry RankSector Rank
ROA -35.77%
ROE -84.89%
ROIC N/A
ROA(3y)-17.6%
ROA(5y)-18.09%
ROE(3y)-48.86%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 19.60%, NLS is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of NLS has declined.
NLS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.28%
GM growth 5Y-18.44%

4

2. Health

2.1 Basic Checks

NLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NLS has more shares outstanding
The number of shares outstanding for NLS has been increased compared to 5 years ago.
The debt/assets ratio for NLS is higher compared to a year ago.

2.2 Solvency

NLS has an Altman-Z score of 1.84. This is not the best score and indicates that NLS is in the grey zone with still only limited risk for bankruptcy at the moment.
NLS has a Altman-Z score of 1.84. This is in the lower half of the industry: NLS underperforms 61.76% of its industry peers.
NLS has a debt to FCF ratio of 1.35. This is a very positive value and a sign of high solvency as it would only need 1.35 years to pay back of all of its debts.
NLS has a Debt to FCF ratio of 1.35. This is in the better half of the industry: NLS outperforms 70.59% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that NLS is not too dependend on debt financing.
NLS has a Debt to Equity ratio of 0.24. This is in the better half of the industry: NLS outperforms 61.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.35
Altman-Z 1.84
ROIC/WACCN/A
WACC11.43%

2.3 Liquidity

A Current Ratio of 1.99 indicates that NLS should not have too much problems paying its short term obligations.
NLS has a Current ratio of 1.99. This is comparable to the rest of the industry: NLS outperforms 50.00% of its industry peers.
NLS has a Quick Ratio of 1.08. This is a normal value and indicates that NLS is financially healthy and should not expect problems in meeting its short term obligations.
NLS has a Quick ratio of 1.08. This is comparable to the rest of the industry: NLS outperforms 44.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.08

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.92% over the past year.
Looking at the last year, NLS shows a very negative growth in Revenue. The Revenue has decreased by -40.47% in the last year.
NLS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.73% yearly.
EPS 1Y (TTM)47.92%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q92.19%
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y-2.49%
Revenue growth 5Y-6.73%
Revenue growth Q2Q-23.84%

3.2 Future

Based on estimates for the next years, NLS will show a very strong growth in Earnings Per Share. The EPS will grow by 35.62% on average per year.
The Revenue is expected to grow by 5.08% on average over the next years.
EPS Next Y80.64%
EPS Next 2Y35.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.27%
Revenue Next 2Y5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NLS. In the last year negative earnings were reported.
Also next year NLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

97.06% of the companies in the same industry are more expensive than NLS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.42
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NLS's earnings are expected to grow with 35.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.62%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NAUTILUS INC

NYSE:NLS (10/31/2023, 8:26:50 PM)

After market: 0.85 +0.03 (+3.61%)

0.8204

+0.08 (+11.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap29.14M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.77%
ROE -84.89%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.6%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.95
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.99
Quick Ratio 1.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)47.92%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y80.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y-2.49%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y